Dexcom (DXCM) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.60% |
| Dec 31, 2025 | -53.20% |
| Sep 30, 2025 | 36.54% |
| Jun 30, 2025 | 44.53% |
| Mar 31, 2025 | 16.36% |
| Dec 31, 2024 | -15.76% |
| Sep 30, 2024 | -0.91% |
| Jun 30, 2024 | 16.60% |
| Mar 31, 2024 | 14.30% |
| Dec 31, 2023 | -16.09% |
| Sep 30, 2023 | -59.12% |
| Jun 30, 2023 | 46.77% |
| Mar 31, 2023 | -0.20% |
| Dec 31, 2022 | -28.89% |
| Sep 30, 2022 | -57.50% |
| Jun 30, 2022 | -37.29% |
| Mar 31, 2022 | -50.29% |
| Dec 31, 2021 | -156.83% |
| Sep 30, 2021 | 94.55% |
| Jun 30, 2021 | 112.48% |
| Mar 31, 2021 | -59.10% |
| Dec 31, 2020 | 182.17% |
| Sep 30, 2020 | 52.00% |
| Jun 30, 2020 | -43.52% |
| Mar 31, 2020 | 58.16% |
| Dec 31, 2019 | 41.80% |
| Sep 30, 2019 | -90.05% |
| Jun 30, 2019 | -173.60% |
| Mar 31, 2019 | 126.19% |
| Dec 31, 2018 | 139.12% |
| Sep 30, 2018 | 66.63% |
| Jun 30, 2018 | -71.48% |
| Mar 31, 2018 | -30.90% |
| Dec 31, 2017 | 64.87% |
| Sep 30, 2017 | 39.33% |
| Jun 30, 2017 | 213.80% |
| Mar 31, 2017 | 86.84% |
| Dec 31, 2016 | 25.21% |
| Sep 30, 2016 | 21.32% |
| Jun 30, 2016 | -20.10% |
| Mar 31, 2016 | -50.84% |
| Dec 31, 2015 | 25.83% |
| Sep 30, 2015 | 104.74% |